Details of the Drug

General Information of Drug (ID: DMSEXNP)

• Drug Name: Sipuleucel-T
• Synonyms: APC8015

Indication

Disease Entry	ICD 11	Status	REF
Prostate cancer	2C82.0	Approved	[1]
Human immunodeficiency virus-1 infection	1C62	Phase 3	[2]

• Affected Organisms: Humans and other mammals
• ATC Code:
  L03AX17: Sipuleucel-T
  L03AX: Other immunostimulants
  L03A: IMMUNOSTIMULANTS
  L03: IMMUNOSTIMULANTS
  L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
• Cross-matching ID:
  UNII: 8Q622VDR18
  DrugBank ID: DB06688
  TTD ID: D01SAY
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services
• [2] ClinicalTrials.gov (NCT01133704) Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer. U.S. National Institutes of Health.